|
Worksteam Leader |
Liz Meehan, AstraZeneca |
||
|
Work Stream Objectives |
Generate understanding around the impact that API physical properties have on drug product process robustness and product quality. | ||
|
Develop API filtration/drying strategies that reduce processing time/cost and minimise negative impact on API physical properties
Demonstrate flexible and agile drug product manufacturing capabilities which implement continuous processing operations, where product is monitored during processing and the process is adjusted based upon input API properties and in-process measurements |
|||
|
Strands summary |
Advanced manufacturing technologies: Hot melt extrusion, Continuous filtration, Direct compression Technology support tools and training packages |
||
|
Partners |
|
|
|
 |
|
 |
|
|
|
|
|
|
Home » Research » Project Structure » Workstream (App) “B” – Primary to Secondary
